Silicone breast implant research on local effects should be "top priority" -- FDA study authors.
This article was originally published in The Gray Sheet
Executive Summary
SILICONE BREAST IMPLANT RUPTURE IMPROVED TEST METHODS NEEDED to provide "more information on rates of rupture in general and the influence of rupture on other local and systemic complications," FDA scientist Barbara Silverman, MD, et al. say in a literature review appearing in the April 15 issue of Annals of Internal Medicine. The article says that information on local effects of the implants, such as rupture, capsular contracture and silicone migration, should be "a top priority on the research agenda."